After years of underperformance, researchers may have discovered what's plaguing the hedge-fund industry: too much testosterone.
Hedge-fund managers with high testosterone underperform those with low testosterone by 5.8 percent each year, according to a study conducted by University of Central Florida and Singapore Management University.
The researchers used software to measure the facial width-to-height ratio — proven to be a proxy for testosterone levels — of more than 3,000 hedge-fund managers. After controlling for variables such as risk and market environment, the researchers found that not only do funds of higher-testosterone managers produce lower returns, but those managers also have a greater propensity to be terminated.


